Keyphrases
Hydrocephalus
100%
Neuroinflammation
100%
Shunt Malfunction
100%
Cerebrospinal Fluid Biomarkers
100%
Interleukin-8
100%
Interleukin-6
85%
Matrix Metalloproteinase 7 (MMP7)
85%
Cerebrospinal Fluid
71%
Interleukin-10
57%
Shunt Failure
57%
Matrix metalloproteinase-9 (MMP-9)
42%
Matrix Metalloproteinases
42%
Inflammatory Cytokines
28%
Protein Concentration
28%
Anti-inflammatory Cytokines
28%
Interleukin-1β
14%
Interleukin-12 (IL-12)
14%
Clinical Outcomes
14%
Protein Level
14%
Cerebrospinal Fluid Shunt
14%
Shunt Revision
14%
Shunt
14%
Interleukin-17 (IL-17)
14%
Patient's Will
14%
Revision Procedure
14%
Interleukin-2
14%
Interleukin-5 (IL-5)
14%
Interleukin-4 (IL-4)
14%
First Year
14%
Anti-neuroinflammation
14%
Interdependency
14%
All Pediatric
14%
Matrix metalloproteinase-3 (MMP-3)
14%
Shunt Obstruction
14%
Cerebrospinal Fluid Protein
14%
Matrix metalloproteinase-2 (MMP-2)
14%
Concentration Profile
14%
Non-obstructive
14%
Multiplex ELISA
14%
7-matrix
14%
Matrix Metalloproteinase Proteins
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cytokine
100%
Interleukin 6
100%
Nervous System Inflammation
100%
Obstruction
100%
Hydrocephalus
100%
Matrilysin
100%
Interleukin 10
66%
Matrix Metalloproteinase
66%
Shunt Failure
66%
Gelatinase B
50%
Anti-Inflammatory Drug
33%
Tumor Necrosis Factor
16%
Interleukin 2
16%
Enzyme-Linked Immunosorbent Assay
16%
Interleukin 5
16%
Interleukin 4
16%
Gelatinase A
16%
Stromelysin
16%
Interleukin 17
16%
Shunt Occlusion
16%
Diseases
16%
Neuroscience
Hydrocephalus
100%
Interleukin 8
100%
Interleukin 6
85%
Matrilysin
85%
Matrix Metalloproteinase
57%
Interleukin 10
57%
MMP9
42%
Proinflammatory Cytokine
28%
Anti-Inflammatory
28%
Interleukin 4
14%
ELISA
14%
Interleukin 2
14%
MMP2
14%
Interleukin 17
14%
Stromelysin
14%
Interleukin 5
14%